Patricia E. Gallagher

7.8k total citations · 1 hit paper
119 papers, 6.2k citations indexed

About

Patricia E. Gallagher is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Patricia E. Gallagher has authored 119 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Cardiology and Cardiovascular Medicine, 40 papers in Endocrinology, Diabetes and Metabolism and 37 papers in Molecular Biology. Recurrent topics in Patricia E. Gallagher's work include Renin-Angiotensin System Studies (49 papers), Hormonal Regulation and Hypertension (34 papers) and Apelin-related biomedical research (13 papers). Patricia E. Gallagher is often cited by papers focused on Renin-Angiotensin System Studies (49 papers), Hormonal Regulation and Hypertension (34 papers) and Apelin-related biomedical research (13 papers). Patricia E. Gallagher collaborates with scholars based in United States, Germany and United Kingdom. Patricia E. Gallagher's co-authors include E. Ann Tallant, Carlos M. Ferrario, K. Bridget Brosnihan, Mark C. Chappell, David B. Averill, Debra I. Diz, Jewell A. Jessup, Yuichiro Ishiyama, William B. Strawn and Nahum J. Duker and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of Clinical Oncology.

In The Last Decade

Patricia E. Gallagher

115 papers receiving 6.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2

2005 1.2k citations Carlos M. Ferrario, Jewell A. Jessup et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Patricia E. Gallagher United States	40	3.0k	2.0k	1.5k	1.5k	792	119	6.2k
K. Bridget Brosnihan United States	44	3.5k 1.1×	3.2k 1.6×	1.2k 0.8×	1.4k 0.9×	850 1.1×	89	7.4k
Susan B. Gurley United States	35	2.2k 0.7×	1.7k 0.9×	1.6k 1.1×	448 0.3×	551 0.7×	85	5.2k
Nancy E. Stagliano United States	19	1.4k 0.5×	813 0.4×	1.2k 0.8×	892 0.6×	455 0.6×	22	4.2k
Yoram Yagil Israel	28	1.3k 0.4×	973 0.5×	957 0.6×	586 0.4×	395 0.5×	96	3.7k
Jiuchang Zhong China	38	1.8k 0.6×	753 0.4×	1.9k 1.2×	551 0.4×	720 0.9×	135	4.7k
Keiji Kuba Japan	29	744 0.2×	360 0.2×	1.3k 0.8×	2.3k 1.5×	649 0.8×	59	5.2k
Kevin D. Burns Canada	42	2.4k 0.8×	1.7k 0.8×	2.0k 1.3×	222 0.1×	558 0.7×	160	6.0k
Steven D. Crowley United States	42	1.9k 0.6×	1.3k 0.7×	2.1k 1.3×	243 0.2×	393 0.5×	109	6.0k
Donald E. Kohan United States	52	3.3k 1.1×	2.6k 1.3×	4.2k 2.7×	214 0.1×	562 0.7×	227	10.7k
Brigitte Rigat Canada	21	3.9k 1.3×	2.6k 1.3×	1.2k 0.8×	96 0.1×	901 1.1×	32	6.5k

Countries citing papers authored by Patricia E. Gallagher

Since Specialization

Citations

This map shows the geographic impact of Patricia E. Gallagher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patricia E. Gallagher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patricia E. Gallagher more than expected).

Fields of papers citing papers by Patricia E. Gallagher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patricia E. Gallagher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patricia E. Gallagher. The network helps show where Patricia E. Gallagher may publish in the future.

Co-authorship network of co-authors of Patricia E. Gallagher

This figure shows the co-authorship network connecting the top 25 collaborators of Patricia E. Gallagher. A scholar is included among the top collaborators of Patricia E. Gallagher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patricia E. Gallagher. Patricia E. Gallagher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Newman, Tiffany M., Adam S. Wilson, Kenysha Y.J. Clear, et al.. (2023). Probiotic and Muscadine Grape Extract Interventions Shift the Gut Microbiome and Improve Metabolic Parameters in Female C57BL/6 Mice. Cells. 12(22). 2599–2599. 2 indexed citations

Schaich, Christopher L., Megan Grabenauer, Brian F. Thomas, et al.. (2016). Medullary Endocannabinoids Contribute to the Differential Resting Baroreflex Sensitivity in Rats with Altered Brain Renin-Angiotensin System Expression. Frontiers in Physiology. 7. 207–207. 12 indexed citations

Brosnihan, K. Bridget, Víctor M. Pulgar, Patricia E. Gallagher, Liomar A. A. Neves, & Liliya M. Yamaleyeva. (2015). Local uterine Ang-(1–7) infusion augments the expression of cannabinoid receptors and differentially alters endocannabinoid metabolizing enzymes in the decidualized uterus of pseudopregnant rats. Reproductive Biology and Endocrinology. 13(1). 5–5. 7 indexed citations

Arnold, Amy C., Patricia E. Gallagher, & Debra I. Diz. (2012). Brain renin–angiotensin system in the nexus of hypertension and aging. Hypertension Research. 36(1). 5–13. 47 indexed citations

Lindsey, Sarah H., Jonathan Cohen, K. Bridget Brosnihan, Patricia E. Gallagher, & Mark C. Chappell. (2009). Chronic Treatment with the G Protein-Coupled Receptor 30 Agonist G-1 Decreases Blood Pressure in Ovariectomized mRen2.Lewis Rats. Endocrinology. 150(8). 3753–3758. 152 indexed citations

Petty, W. Jeffrey, Antonius A. Miller, Thomas P. McCoy, et al.. (2009). Phase I and Pharmacokinetic Study of Angiotensin-(1-7), an Endogenous Antiangiogenic Hormone. Clinical Cancer Research. 15(23). 7398–7404. 77 indexed citations

Greenberg, Stephen & Patricia E. Gallagher. (2009). The great contribution: Index Medicus, Index-Catalogue, and IndexCat. Journal of the Medical Library Association JMLA. 97(2). 108–113. 7 indexed citations

Brosnihan, K. Bridget, Jeffrey B. Hodgin, Oliver Smithies, Nobuyo Maeda, & Patricia E. Gallagher. (2008). Tissue‐specific regulation of ACE/ACE2 and AT₁/AT₂ receptor gene expression by oestrogen in apolipoprotein E/oestrogen receptor‐α knock‐out mice. Experimental Physiology. 93(5). 658–664. 78 indexed citations

Diz, Debra I., Marı́a A. Garcı́a-Espinosa, Patricia E. Gallagher, et al.. (2008). Angiotensin-(1-7) and Baroreflex Function in Nucleus Tractus Solitarii of (mRen2)27 Transgenic Rats. Journal of Cardiovascular Pharmacology. 51(6). 542–548. 49 indexed citations

10.

Neves, Liomar A. A., JaNae Joyner, Gloría Valdés, et al.. (2007). ACE2 and ANG-(1-7) in the rat uterus during early and late gestation. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 294(1). R151–R161. 83 indexed citations

11.

Whaley‐Connell, Adam, Melvin R. Hayden, Craig S. Stump, et al.. (2006). Oxidative stress and glomerular filtration barrier injury: role of the renin-angiotensin system in the Ren2 transgenic rat. American Journal of Physiology-Renal Physiology. 291(6). F1308–F1314. 105 indexed citations

12.

Neves, Liomar A. A., Mark C. Chappell, Carlos M. Ferrario, et al.. (2006). Effect of estrogen on neprilysin expression in uterus and kidney of Sprague–Dawley normotensive and heterozygous (mRen2)27-transgenic hypertensive rats. Peptides. 27(11). 2912–2918. 14 indexed citations

13.

Strawn, William B., et al.. (2004). Renin–angiotensin system expression in rat bone marrow haematopoietic and stromal cells. British Journal of Haematology. 126(1). 120–126. 109 indexed citations

14.

Diz, Debra I., et al.. (2002). Angiotensin Peptides As Neurotransmitters/ Neuromodulators In The Dorsomedial Medulla. Clinical and Experimental Pharmacology and Physiology. 29(5-6). 473–482. 58 indexed citations

15.

Strawn, William B., Patricia E. Gallagher, E. Ann Tallant, Detlev Ganten, & Carlos M. Ferrario. (1999). Angiotensin II AT1-Receptor Blockade Inhibits Monocyte Activation and Adherence in Transgenic (mRen2)27 Rats. Journal of Cardiovascular Pharmacology. 33(3). 341–351. 31 indexed citations

16.

Gallagher, Patricia E., et al.. (1993). In vivo REPAIR OF CYTOSINE HYDRATES IN DNA OF CULTURED HUMAN LYMPHOBLASTS. Photochemistry and Photobiology. 58(2). 219–225. 7 indexed citations

17.

Singer, Brett C., Antonio Antoccia, Ashis K. Basu, et al.. (1992). Both purified human 1,N6-ethenoadenine-binding protein and purified human 3-methyladenine-DNA glycosylase act on 1,N6-ethenoadenine and 3-methyladenine.. Proceedings of the National Academy of Sciences. 89(20). 9386–9390. 93 indexed citations

18.

Gallagher, Patricia E., et al.. (1989). Cytosine photoproduct-DNA glycosylase in Escherichia coli and cultured human cells. Biochemistry. 28(4). 1488–1492. 20 indexed citations

19.

Gallagher, Patricia E., et al.. (1989). A Human Endonuclease Incises Ultraviolet‐Irradiated DNA at Cytosines and Oxidized DNA at Thymines. Molecular Carcinogenesis. 2(4). 188–191. 3 indexed citations

20.

Kumar, Rajendra, et al.. (1988). Pseudocyst following splenectomy: Impact of CT and ultrasound on its diagnosis and management. Abdominal Imaging. 13(1). 177–179.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact